These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 8455928)
1. Activation of c-mos oncogene by integration of an endogenous long terminal repeat element during transfection of genomic DNA from mouse skin tumor cells. Wang S; Nishigori C; Miyakoshi J; Tsukada T; Shung B; Yagi T; Takebe H Oncogene; 1993 Apr; 8(4):1009-16. PubMed ID: 8455928 [TBL] [Abstract][Full Text] [Related]
2. Oncogenic activation of murine mos protein kinase by DNA rearrangement of its N-terminal coding region. Ohuchi T; Kurita Y; Sasai H; Miyoshi J; Nomura T; Toyoshima K Oncogene; 1992 Feb; 7(2):331-8. PubMed ID: 1532243 [TBL] [Abstract][Full Text] [Related]
3. Activation of the mas oncogene involves coupling to human alphoid sequences. van 't Veer LJ; van der Feltz MJ; van den Berg-Bakker CA; Cheng NC; Hermens RP; van Oorschot DA; Kievits T; Schrier PI Oncogene; 1993 Oct; 8(10):2673-81. PubMed ID: 8378079 [TBL] [Abstract][Full Text] [Related]
4. Characterization of activated and normal mouse Mos gene in murine 3T3 cells. Paules RS; Resnick J; Kasenally AB; Ernst MK; Donovan P; Vande Woude GF Oncogene; 1992 Dec; 7(12):2489-98. PubMed ID: 1461652 [TBL] [Abstract][Full Text] [Related]
5. Control of endogenous mouse mammary tumor virus superantigen expression in SJL lymphomas by a promoter within the env region. Zhang DJ; Tsiagbe VK; Huang C; Thorbecke GJ J Immunol; 1996 Oct; 157(8):3510-7. PubMed ID: 8871650 [TBL] [Abstract][Full Text] [Related]
6. Detection and identification of activated oncogenes in human skin cancers occurring on sun-exposed body sites. Ananthaswamy HN; Price JE; Goldberg LH; Bales ES Cancer Res; 1988 Jun; 48(12):3341-6. PubMed ID: 3370635 [TBL] [Abstract][Full Text] [Related]
8. Differential regulation of c-fos expression in estrogen-induced hamster renal tumors compared with kidney not due to creation of an estrogen-response element by point mutation in the gene's flanking sequence. Sarabia SF; Liehr JG Mol Carcinog; 1999 Apr; 24(4):255-62. PubMed ID: 10326862 [TBL] [Abstract][Full Text] [Related]
9. Deregulated expression of c-mos in non-small cell lung carcinomas: relationship with p53 status, genomic instability, and tumor kinetics. Gorgoulis VG; Zacharatos P; Mariatos G; Liloglou T; Kokotas S; Kastrinakis N; Kotsinas A; Athanasiou A; Foukas P; Zoumpourlis V; Kletsas D; Ikonomopoulos J; Asimacopoulos PJ; Kittas C; Field JK Cancer Res; 2001 Jan; 61(2):538-49. PubMed ID: 11212247 [TBL] [Abstract][Full Text] [Related]
10. Detection of c-mos proto-oncogene expression in human cells. Li CC; Chen E; O'Connell CD; Longo DL Oncogene; 1993 Jun; 8(6):1685-91. PubMed ID: 8502488 [TBL] [Abstract][Full Text] [Related]
11. Coamplification in tumors of KRAS2, type 2 inositol 1,4,5 triphosphate receptor gene, and a novel human gene, KRAG. Heighway J; Betticher DC; Hoban PR; Altermatt HJ; Cowen R Genomics; 1996 Jul; 35(1):207-14. PubMed ID: 8661122 [TBL] [Abstract][Full Text] [Related]
12. Direct relationship between the expression of tumor suppressor H19 mRNA and c-mos proto-oncogene during myogenesis. Leibovitch MP; Solhonne B; Guillier M; Verrelle P; Leibovitch SA; Verelle P [corrected to Verrelle P] Oncogene; 1995 Jan; 10(2):251-60. PubMed ID: 7838525 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of melanoma-associated antigen expression and ecotropic retrovirus production in B16BL6 melanoma cells transfected with major histocompatibility complex class I genes. Li M; Muller J; Xu F; Hearing VJ; Gorelik E Cancer Res; 1996 Oct; 56(19):4464-74. PubMed ID: 8813142 [TBL] [Abstract][Full Text] [Related]
14. Negative and positive effects of an IAP-LTR on nearby Pcdaalpha gene expression in the central nervous system and neuroblastoma cell lines. Sugino H; Toyama T; Taguchi Y; Esumi S; Miyazaki M; Yagi T Gene; 2004 Aug; 337():91-103. PubMed ID: 15276205 [TBL] [Abstract][Full Text] [Related]
15. Genomic architecture and transcriptional activation of the mouse and human tumor susceptibility gene TSG101: common types of shorter transcripts are true alternative splice variants. Wagner KU; Dierisseau P; Rucker EB; Robinson GW; Hennighausen L Oncogene; 1998 Nov; 17(21):2761-70. PubMed ID: 9840940 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells. Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899 [TBL] [Abstract][Full Text] [Related]
17. Loss of glucocorticoid-dependent growth inhibition in transformed mouse lung cells. Li J; Johnson TA; Hanson LA; Beer DG Mol Carcinog; 1996 Aug; 16(4):213-20. PubMed ID: 8784464 [TBL] [Abstract][Full Text] [Related]
18. Genetic instability of a MoMLV-based antisense double-copy retroviral vector designed for HIV-1 gene therapy. Junker U; Böhnlein E; Veres G Gene Ther; 1995 Nov; 2(9):639-46. PubMed ID: 8548553 [TBL] [Abstract][Full Text] [Related]
19. Exon 4-encoded acidic domain in the epithelium-restricted Ets factor, ESX, confers potent transactivating capacity and binds to TATA-binding protein (TBP). Chang CH; Scott GK; Baldwin MA; Benz CC Oncogene; 1999 Jun; 18(25):3682-95. PubMed ID: 10391676 [TBL] [Abstract][Full Text] [Related]